Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method
Abstract Background Lymphangioleiomyomatosis (LAM) is included within group 5 of the current PH classification (unclear multifactorial mechanisms). However, data regarding the occurrence of PH in LAM are scarce. The aims of the study were to describe the prevalence and characteristics of PH in a lar...
Main Authors: | Carolina S. G. Freitas, Bruno G. Baldi, Carlos Jardim, Mariana S. Araujo, Juliana Barbosa Sobral, Gláucia I. Heiden, Ronaldo A. Kairalla, Rogério Souza, Carlos R. R. Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-017-0626-0 |
Similar Items
-
Pulmonary lymphangioleiomyomatosis (PLAM)
by: Verma S, et al.
Published: (2007-01-01) -
Evolução da função pulmonar após tratamento com goserelina em pacientes com linfangioleiomiomatose Evolution of pulmonary function after treatment with goserelin in patients with lymphangioleiomyomatosis
by: Bruno Guedes Baldi, et al.
Published: (2011-06-01) -
Advances in the Diagnosis, Treatment and Prognosis of Lymphangioleiomyomatosis
by: CHENG Chongsheng, et al.
Published: (2022-01-01) -
Advances in imaging study of pulmonary lymphangioleiomyomatosis
by: LIKE Lahu, YANG Wenjie
Published: (2022-12-01) -
Physiotherapy in lymphangioleiomyomatosis: a systematic review
by: Victoria Maria Garcia de Medeiros, et al.
Published: (2022-12-01)